Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone

Caitlin E. Cox

May 20, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Emulsifiers in Food Up CVD Risk and Should Be Avoided, Study Urges

Yael L. Maxwell

September 21, 2023

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2023

Shelley Wood

May 31, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Daily News

Statins Underprescribed in PAD Before and After Interventions

L.A. McKeown

December 03, 2021

News Daily News

CV Complications of Malaria Rare but Portend Poor Prognosis

Michael O'Riordan

February 22, 2021

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes

Shelley Wood

September 28, 2016

Advertisement

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone

Top Endovascular News of 2023

AHA Selects 2023’s Leading Cardiovascular Research

Emulsifiers in Food Up CVD Risk and Should Be Avoided, Study Urges

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

TCTMD’s Top 10 Most Popular Stories for May 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

Top Endovascular News of 2022

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

TCTMD’s Top 10 Most Popular Stories for November 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Statins Underprescribed in PAD Before and After Interventions

CV Complications of Malaria Rare but Portend Poor Prognosis

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content